Application Information

This drug has been submitted to the FDA under the reference 022271/001.

Names and composition

"NESINA" is the commercial name of a drug composed of ALOGLIPTIN BENZOATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022271/001 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 6.25MG BASE
022271/002 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 12.5MG BASE
022271/003 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 25MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022271/001 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 6.25MG BASE
022271/002 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 12.5MG BASE
022271/003 NESINA ALOGLIPTIN BENZOATE TABLET/ORAL EQ 25MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved